mescaline has been researched along with Psychotic Disorders in 28 studies
Mescaline: Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.
mescaline : A phenethylamine alkaloid that is phenethylamine substituted at positions 3, 4 and 5 by methoxy groups.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (96.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nelson, B | 1 |
| Sass, LA | 1 |
| TEIRICH, H | 1 |
| SCHWARZ, BE | 1 |
| SEM-JACOBSEN, CW | 1 |
| PETERSEN, MC | 1 |
| POSTEL, J | 1 |
| COSSA, P | 1 |
| JOST, F | 1 |
| PEMSL, H | 1 |
| STEVENSON, I | 2 |
| SANCHEZ, AJ | 1 |
| TONINI, G | 2 |
| HOCH, PH | 1 |
| MOKRASCH, LC | 1 |
| DENBER, HC | 1 |
| WAHL, M | 1 |
| VOJTECHOVSKY, M | 1 |
| GROF, S | 1 |
| TOLAN, EJ | 1 |
| LINGL, FA | 1 |
| HOLLISTER, LE | 1 |
| SHULGIN, AT | 1 |
| LEUNER, H | 1 |
| PELICIER, Y | 1 |
| LUDWIG, AM | 1 |
| LEVINE, J | 1 |
| FABING, HD | 1 |
| MISSERE, G | 1 |
| Bron, B | 1 |
| Johnston, VS | 2 |
| Bradley, RJ | 2 |
| Hole, G | 1 |
| Brodsky, L | 1 |
| Bowers, MB | 1 |
| Giacobini, E | 1 |
| Smythies, JR | 1 |
| Iriye, TT | 1 |
| Kuna, A | 1 |
| Simmonds, FA | 1 |
4 reviews available for mescaline and Psychotic Disorders
| Article | Year |
|---|---|
CHEMICAL PSYCHOSES.
Topics: Adrenochrome; Cannabis; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Metabolism; Ps | 1964 |
Molecular pharmacology of hallucinogens.
Topics: Amphetamine; Animals; Avoidance Learning; Brain; Conditioning, Operant; Emotions; Hallucinogens; Hum | 1968 |
[LSD and related hallucinogens. History--effect--use and dangers].
Topics: Autonomic Nervous System; Cannabis; Chemistry; Culture; Hallucinogens; History, 20th Century; Humans | 1967 |
A biochemical survey of schizophrenia.
Topics: Amines; Amphetamine; Antibodies; Antigen-Antibody Reactions; Antimetabolites; Biotransformation; Blo | 1970 |
24 other studies available for mescaline and Psychotic Disorders
| Article | Year |
|---|---|
The phenomenology of the psychotic break and Huxley's trip: substance use and the onset of psychosis.
Topics: Affect; Awareness; Delusions; Hallucinations; Hallucinogens; Humans; Illicit Drugs; Marijuana Abuse; | 2008 |
[Injurious effects of mescaline].
Topics: Alkaloids; Humans; Mental Disorders; Mescaline; Psychoses, Substance-Induced; Psychotic Disorders | 1954 |
Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man.
Topics: Adrenochrome; Electroconvulsive Therapy; Electroencephalography; Ergot Alkaloids; Humans; Lysergic A | 1956 |
[Treatment by induced psychosis (mescaline and chlorpromazine)].
Topics: Chlorpromazine; Mental Disorders; Mescaline; Phenethylamines; Psychotic Disorders; Schizophrenia; Sh | 1956 |
[Prospective psychiatry; the time factor].
Topics: Humans; Lysergic Acid Diethylamide; Mescaline; Prospective Studies; Psychiatry; Psychosurgery; Psych | 1957 |
The antidotal action of sodium succinate in the mescaline psychosis.
Topics: Central Nervous System Stimulants; Humans; Mental Disorders; Mescaline; Psychotic Disorders; Sodium; | 1957 |
[Importance of psychopathological factors & drug dosage in experimental psychoses].
Topics: Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychopathology; Psychotic Disorders | 1957 |
Psychoses-producing and psychoses-relieving drugs.
Topics: Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychotic Disorders | 1958 |
A further note on the mechanism of the antidotal action of sodium succinate in the mescaline psychosis.
Topics: Central Nervous System Stimulants; Humans; Mental Disorders; Mescaline; Psychoses, Substance-Induced | 1958 |
Studies on mescaline. VIII. Psychodynamic observations.
Topics: Counseling; Electroconvulsive Therapy; Humans; Mescaline; Psychotherapy; Psychotic Disorders | 1958 |
[Peyote alkaloids in the therapy of autonomic neurological conditions & especially in rheumatic heart disease & presenile states].
Topics: Autonomic Nervous System; Autonomic Nervous System Diseases; Dementia; Humans; Mescaline; Psychotic | 1958 |
[Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].
Topics: Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychotic Disorders | 1960 |
"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.
Topics: Adolescent; Gasoline; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Diso | 1964 |
3-METHOXY-4,5-METHYLENEDIOXY AMPHETAMINE, A NEW PSYCHOTOMIMETIC AGENT.
Topics: Amphetamine; Amphetamines; Dogs; Hallucinogens; Mental Disorders; Mescaline; Mice; Oils; Oils, Volat | 1964 |
[FUNDAMENTALS OF A CONDITIONAL-GENETIC PSYCHOPATHOLOGY AS EXEMPLIFIED BY EXPERIMENTAL PSYCHOSIS].
Topics: Hallucinogens; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Neurotic Disorders; Psilocyb | 1963 |
[SEROTONIN AND PSYCHIATRY].
Topics: Bipolar Disorder; Catecholamines; Drug Therapy; Hallucinations; Hallucinogens; Humans; Hydroxyindole | 1964 |
PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
Topics: Amphetamine; Amphetamines; Barbiturates; Cannabis; Drug and Narcotic Control; Hallucinogens; Humans; | 1965 |
Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
Topics: Central Nervous System Stimulants; Ergot Alkaloids; Humans; Lysergic Acid Diethylamide; Mental Disor | 1955 |
[Experimental contribution to the problem of possible crossed tolerance between psychotic drugs of different structure].
Topics: Central Nervous System; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Nervous Sys | 1959 |
[The psychopathology of early and chronic psychotic symptoms in young drug-users].
Topics: Adolescent; Adult; Bipolar Disorder; Cannabis; Female; Humans; Lysergic Acid Diethylamide; Male; Mes | 1976 |
Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings.
Topics: Acute Disease; Adolescent; Adult; Amphetamine; Delusions; Diagnosis, Differential; Female; Hallucino | 1972 |
[Biochemical psychotherories. Where do we stand in 1971? 1. Monoamine theories].
Topics: Amines; Ceruloplasmin; Epinephrine; Hallucinogens; Humans; Mescaline; Phenethylamines; Psychotic Dis | 1971 |
Behavioural models of psychosis.
Topics: Amines; Amphetamine; Animals; Avoidance Learning; Brain Chemistry; Chemistry, Pharmaceutical; Chlorp | 1969 |
Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers.
Topics: Animals; Brain; Chlorpromazine; Dextroamphetamine; Glycogen; Hallucinogens; Humans; Hydrocortisone; | 1965 |